이 유전자는 효소의 시토크롬 P450 슈퍼패밀리의 구성원을 암호로 한다.시토크롬 P450 단백질은 약물 대사 및 콜레스테롤, 스테로이드 및 기타 지질의 합성에 관련된 많은 반응을 촉진하는 단옥시겐이다.이 단백질은 소포체 망막까지 국소화된다.설치류에서 호몰로겐 단백질은 특정 발암물질을 대사시키는 것으로 나타났지만, 인간 단백질의 특정한 기능은 결정되지 않았다.[5]
Windmill KF, McKinnon RA, Zhu X, et al. (1997). "The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies". Mutat. Res. 376 (1–2): 153–60. doi:10.1016/S0027-5107(97)00038-9. PMID9202751.
Hakkola J, Pelkonen O, Pasanen M, Raunio H (1998). "Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity". Crit. Rev. Toxicol. 28 (1): 35–72. doi:10.1080/10408449891344173. PMID9493761.
Nhamburo PT, Gonzalez FJ, McBride OW, et al. (1990). "Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping". Biochemistry. 28 (20): 8060–6. doi:10.1021/bi00446a014. PMID2574990.
McKinnon RA, Burgess WM, Gonzalez FJ, et al. (1995). "Species-specific expression of CYP4B1 in rabbit and human gastrointestinal tissues". Pharmacogenetics. 4 (5): 260–70. doi:10.1097/00008571-199410000-00004. PMID7894498.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Czerwinski M, McLemore TL, Gelboin HV, Gonzalez FJ (1994). "Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors". Cancer Res. 54 (4): 1085–91. PMID8313365.
Hakkola J, Raunio H, Purkunen R, et al. (1996). "Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy". Biochem. Pharmacol. 52 (2): 379–83. doi:10.1016/0006-2952(96)00216-X. PMID8694864.
Hukkanen J, Hakkola J, Anttila S, et al. (1997). "Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes". Mol. Carcinog. 20 (2): 224–30. doi:10.1002/(SICI)1098-2744(199710)20:2<224::AID-MC9>3.0.CO;2-M. PMID9364212.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Hukkanen J, Mäntylä M, Kangas L, et al. (1998). "Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium". Pharmacol. Toxicol. 82 (2): 93–7. doi:10.1111/j.1600-0773.1998.tb01404.x. PMID9498238.
Imaoka S, Yoneda Y, Sugimoto T, et al. (2000). "CYP4B1 is a possible risk factor for bladder cancer in humans". Biochem. Biophys. Res. Commun. 277 (3): 776–80. doi:10.1006/bbrc.2000.3740. PMID11062028.
Henne KR, Kunze KL, Zheng YM, et al. (2001). "Covalent linkage of prosthetic heme to CYP4 family P450 enzymes". Biochemistry. 40 (43): 12925–31. doi:10.1021/bi011171z. PMID11669629.
Iscan M, Klaavuniemi T, Coban T, et al. (2002). "The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue". Breast Cancer Res. Treat. 70 (1): 47–54. doi:10.1023/A:1012526406741. PMID11767004. S2CID25813919.
Lo-Guidice JM, Allorge D, Cauffiez C, et al. (2003). "Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant". Pharmacogenetics. 12 (5): 367–74. doi:10.1097/00008571-200207000-00004. PMID12142726.
Wtsi.jpg)
